Repligen (RGEN) Amortizatization of Intangibles (2016 - 2026)
Repligen (RGEN) reported Amortizatization of Intangibles of $4.8 million for Q1 2026, up 6.49% year-over-year from $4.5 million in Q1 2025, and up 2.89% quarter-over-quarter from $4.6 million in Q4 2025.
Repligen (RGEN) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Repligen (RGEN) has 11 years of Amortizatization of Intangibles data on file, last reported at $4.8 million in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $4.8 million, up 6.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.5 million (up 19.61% YoY), and the FY2025 annual result was $18.2 million, up 7.83% from the prior year.
- Amortizatization of Intangibles climbed to $4.8 million in Q1 2026 per RGEN's latest filing, from $4.6 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $16.2 million in Q4 2023 and troughed at -$905000.0 in Q3 2022.
- A 5-year average of $3.4 million and a median of $3.5 million in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles slumped 136.2% in 2022, then surged 791.74% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.8 million in 2022, then soared by 791.74% to $16.2 million in 2023, then plunged by 74.42% to $4.1 million in 2024, then increased by 12.1% to $4.6 million in 2025, then advanced by 2.89% to $4.8 million in 2026.
- Business Quant data shows RGEN's Amortizatization of Intangibles at $4.8 million in Q1 2026, $4.6 million in Q4 2025, and $5.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 10.20 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 10.05 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 600,000.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 10.06 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Sep 30, 2025 | 5.41 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.14 Mn |
| Dec 31, 2024 | 4.14 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 3.40 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Mar 31, 2024 | 3.81 Mn |
| Dec 31, 2023 | 16.19 Mn |
| Dec 31, 2023 | 16.19 Mn |